Trade Mark Journal No.2025/035 29 August 2025

WO0000001869853 (5)

Office of origin: United States of America

Date of International Registration:18 July 2025
Date of designation in the UK: 18 July 2025
Image for mark 1869853 JAVADIN

International priority date claimed: 21 January 2025 (United States of America) (99013829)
Class 5
Pharmaceutical preparations for treating hypertension.

Azurity Pharmaceuticals, Inc.

Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA